Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Endothelial Dysfunction During Chronic Administration of Vardenafil in Patients With Type 2 Diabetes Mellitus: A Longitudinal, Randomised, Placebo-controlled, Double Blind, Phase II b, Clinical Trial

NCT02219646 is registered in ClinicalTrials.gov with Azienda USL Modena as lead sponsor.

NCT NCT02219646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02219646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Endothelial Dysfunction During Chronic Administration of Vardenafil in Patients With Type 2 Diabetes Mellitus: A Longitudinal, Randomised, Placebo-controlled, Double Blind, Phase II b, Clinical Trial
Lead sponsor
Azienda USL Modena
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
February 28, 2014
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, erectile dysfunction, type 2 diabetes mellitus (t2dm)